drugset / Trial / NCT02024581

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum

NCT02024581

Phase 2 Terminated 27 enrolled ViroXis Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial will examine the safety, tolerability and efficacy of one strength of East Indian sandalwood oil (EISO) in a cream base compared to a placebo for treatment of molluscum contagiosum in pediatric subjects. Trial participants will be asked to apply study medication twice a day for sixty (60) days. Efficacy will be evaluated by clinical staff and patients will be asked to assess tolerability as well as any improvement experienced during the trial.

Timeline

Start
2016-02
Primary completion
2017-09
Completion
2017-09-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Essential oils Unknown 10 % Topical

Indications